Hawler Medical University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Erbil Iraq (2005)

Organization Overview

First Clinical Trial
2007
NCT00892229
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Hawler Medial University | Hawler Medical University | Hawler Medical University, college of Medicine, department of Obstetrics and Gynecology | Hawler Medical University, College of Pharmacy, Department of Pharmacology and Toxicology | Rheumatology,Hawler medical uiversity,Kurdistan Board for medical specialities | Rheumatology,Hawler medical university | Rheumatology, Hawler medical university/college of medicine | Rheumatology , Hawler Medical University, Kurdistan Board for medical specialties

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abortion, Missed (Phase 2)

Hemorrhage (Phase 2)

Placenta, Retained (Phase 2)

Postpartum Hemorrhage (Phase 2)

Stillbirth (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 18
  • # of Trial APIs: 15